文献速递中毒与环境急症消化、代谢与肾脏急症

处方限制放宽时代急诊医生使用丁丙诺啡的实用综述

A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions.
PubMed 文献 · Am J Emerg Med · 2021-07-05
一句话结论急诊医生应熟悉丁丙诺啡治疗阿片戒断与成瘾,处方限制已放宽,可影响阿片相关病死率。

本文为叙述性综述,通过PubMed检索(关键词包括opioid epidemic、buprenorphine、medication assisted therapy、emergency department)汇总丁丙诺啡在急诊中治疗阿片使用障碍(OUD)的证据。多项研究提示急诊使用丁丙诺啡治疗OUD有效且优于标准治疗,但存在多种使用障碍。2021年4月处方限制放宽,预期急诊使用将增加。结论是急诊医生可通过熟悉丁丙诺啡治疗阿片戒断与成瘾来影响阿片相关 morbidity 与 mortality,仍需进一步急诊研究评估最佳使用。

要点

  • 2021年4月处方限制放宽后,预期急诊丁丙诺啡使用增加,急诊医生需适应变化。
  • 多项研究提示急诊用丁丙诺啡治疗OUD有效且优于标准治疗,但存在多种急诊使用障碍。
  • 急诊医生可通过熟悉丁丙诺啡治疗阿片戒断与成瘾来影响阿片相关 morbidity 与 mortality。
  • 仍需进一步急诊研究评估丁丙诺啡在急诊的最佳使用。

适用人群与场景

  • 急诊科阿片使用障碍(OUD)患者,用于治疗阿片戒断与成瘾。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 叙述性综述,通过PubMed检索关键词包括opioid epidemic、buprenorphine、medication assisted therapy、emergency department,纳入含阿片流行、药物辅助治疗、丁丙诺啡生物学效应且与疼痛管理和急诊相关的文章。
  • 多项研究指出急诊使用丁丙诺啡治疗OUD有效且优于标准治疗,但存在多种急诊使用障碍。

证据类型、等级与局限

  • 证据类型为叙述性综述(narrative review),未提供证据等级或推荐强度;局限包括非系统评价、检索策略与纳入标准描述有限,且原文指出仍需进一步急诊研究评估最佳使用。

对床旁实践的改变

  • 急诊医生应熟悉丁丙诺啡用于治疗阿片戒断与成瘾,尤其在处方限制放宽后;原文未提供具体剂量、流程或适用/不适用人群细节。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Opioid abuse and overdose deaths have reached epidemic proportions in the last couple decades. In response to rational prescribing initiatives, utilization of prescription opioids has decreased; however, the number of deaths due to opioid overdoses continues to rise, largely driven by fentanyl analogues in adulterated heroin. Solutions to the opioid crisis must be multifaceted and address underlying opioid addiction. In recent years, buprenorphine has become a cornerstone in the treatment of opioid use disorder (OUD) and initiation of therapy in the emergency department (ED) has become increasingly common. There have also been calls by many organizations to remove the requirement for additional training and X-waiver to prescribe buprenorphine. In April 2021, the Biden Administration eased prescribing restrictions on the drug. These initiatives are expected to increase ED utilization of the buprenorphine. The purpose of this paper is to provide an updated overview of the role and use of buprenorphine in the ED setting so physicians may adapt to the changing practice environment.

OBJECTIVES: This is a narrative review describing the role of buprenorphine in the ED. A PubMed search was conducted using the keywords "opioid epidemic" "buprenorphine," and "medication assisted therapy", and "emergency department". All the articles that contained information on the opioid epidemic, medication assisted therapy, and the biological effects of buprenorphine, that were also relevant to pain management and the ED, were included in the review.

DISCUSSION: Multiple studies have pointed to the effective use of buprenorphine as a treatment for OUDs in ED patients and are superior to standard care; however, there are various barriers to its use in the ED setting.

CONCLUSION: Emergency physicians can influence opioid related morbidity and mortality, by familiarizing themselves with the use of buprenorphine to treat opioid withdrawal and addiction, particularly now that prescribing restrictions have been eased. Further ED research is necessary to assess the optimal use of buprenorphine in this care setting.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Pourmand A, Beisenova K, Shukur N, et al. A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions. Am J Emerg Med. 2021. PMID: 34274576. doi:10.1016/j.ajem.2021.06.065

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。